Epanova® for Lowering Very High Triglycerides

Clinical trial NCT01242527 · COMPLETED

Trial details

NCT number: NCT01242527
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Severe Hypertriglyceridemia

Start date: 2011-01-01
Primary completion: 2012-03-01
Enrollment: 399

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.